Home > Healthcare > Medical Devices > Diagnostic Devices > Dermal Toxicity Testing Market

Dermal Toxicity Testing Market Share

Report ID: GMI7561
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Dermal Toxicity Testing Market Share

The dermal toxicity testing industry is fragmented, with key players including Eurofins Scientific, MatTek Corporation and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, on September 14, 2023, MatTek expanded its culture ware range by introducing Ultra Low Attachment (ULA) Spheroid Plates for advanced spheroid cell culture applications. These plates, offered in collaboration with faCellitate, are sold under the BIOFLOAT brand in both 96-well and 384-well formats, thereby enhancing sales of dermal toxicity testing benefitting the industry players.

Some of the eminent market participants operating in the dermal toxicity testing industry include:

QIMA LTD
Charles River Laboratories
Evotec
MatTek Corporation
Eurofins Scientific
SGS Group
Intertek Group
InVivo Biosystems
Eurofins Scientific
Qiagen N.V.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The dermal toxicity testing industry was valued at USD 2.1 billion in 2022 and is estimated to reach USD 4.5 billion by 2032 as there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures.

The in-vitro testing segment had a market share of over 42% in 2022 and will grow through 2032 due to advancements in cell culture technologies that have improved the reliability and relevance of in-vitro models.

U.S. dermal toxicity testing market accounted for over USD 1.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to an increased emphasis on alternatives to traditional animal testing methods.

QIMA LTD, Charles River Laboratories, Evotec, MatTek Corporation, Eurofins Scientific, SGS Group, Intertek Group, InVivo Biosystems, Eurofins Scientific, and Qiagen N.V.